encainide has been researched along with Liver Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorne, JL; Renwick, AG; Slob, W; Walton, K | 1 |
| Roden, DM; Turgeon, J | 1 |
| Gallo, DG; Quart, BD; Sami, MH; Wood, AJ | 1 |
| Roden, DM; Woosley, RL | 1 |
1 review(s) available for encainide and Liver Dysfunction
| Article | Year |
|---|---|
Clinical pharmacokinetics of encainide.
Topics: Anilides; Anti-Arrhythmia Agents; Biotransformation; Encainide; Half-Life; Health Status; Humans; Kidney Diseases; Liver Diseases | 1988 |
3 other study(ies) available for encainide and Liver Dysfunction
| Article | Year |
|---|---|
Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?
Topics: Adult; Aged; Aging; Benzhydryl Compounds; Cresols; Cyclohexanols; Cytochrome P-450 CYP2D6; Debrisoquin; Desipramine; Encainide; Ethnicity; Genetic Variation; Humans; Hydroxylation; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Metoprolol; Phenylpropanolamine; Polymorphism, Genetic; Propafenone; Substrate Specificity; Tolterodine Tartrate; Venlafaxine Hydrochloride | 2002 |
Pharmacokinetic profile of encainide.
Topics: Anilides; Encainide; Humans; Kidney Diseases; Liver Diseases | 1989 |
Drug interaction studies and encainide use in renal and hepatic impairment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anilides; Anti-Arrhythmia Agents; Anticoagulants; Antipsychotic Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cimetidine; Digoxin; Diuretics; Drug Interactions; Encainide; Humans; Hypoglycemic Agents; Kidney Diseases; Liver Diseases; Middle Aged; Prospective Studies; Protein Binding; Retrospective Studies | 1986 |